Ocuphire Pharma Investor Day Presentation Deck

APX3330 Preclinical & IND-Enabling Studies DME Extensively Evaluated in Over 20 Studies by Large Japanese Pharma Eisai DR 15 Toxicology Studies 11 PK, Absorption, Distribution, & Excretion Studies APX3330 Investigator Brochure 3 Safety Pharmacology Studies 1 Geno Tox, Repro Tox & Antigenicity Studies 6 Pharmacology Models of Retinal Disease Studies Extensively Studied in Over 20 In-Vitro and Animal Studies with Favorable Efficacy and Safety 4 Ocuphire PHARMA

View entire presentation